why choose us

First received: November 09, 2022

Clinical Trial: Molecular Imaging of Myocardial Fibrosis in Cardiac Amyloidosis

Study Status: Completed

Recruit Status: RECRUITING

Condition: Cardiac Amyloidosis

Study Type: INTERVENTIONAL


Official Title: Molecular Imaging of Myocardial Fibrosis in Cardiac Amyloidosis

Brief Summary: The primary aim of our pilot study is to determine whether fibrosis in the heart can be measured with [68Ga]CBP8, a positron emission tomography (PET) probe, using PET/magnetic resonance imaging (MRI) imaging, in 30 individuals with documented cardiac amyloidosis.The investigators will also enroll 15 individuals with recent myocardial infarction and 15 individuals with hypertrophic cardiomyopathy as positive controls for fibrosis, and the investigators will enroll 5 individuals without cardiovascular disease…

Read more